Postmarket Drug Safety Information for Patients and Providers

In accordance with Section 915 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), this website contains links to postmarket drug safety information to improve transparency and communication to patients and healthcare providers.

Latest Safety Information

Studies and Clinical Trials of Approved Products

General Health Information

  • MedlinePlus
    Authoritative drug and health information from the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Drug Labeling

  • Drugs@FDA
    Approved Professional, Patient Labeling, and Patient Package Inserts in Drugs@FDA
  • DailyMed (National Library of Medicine)
    Drug labeling on this Web site is the most recent submitted to FDA and currently in use; it may include, for example, strengthened warnings undergoing FDA review or minor editorial changes. (updated daily)
  • Medication Guides
    List of Products with Medication Guides

Consumer Information

Page Last Updated: 11/01/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English